Pillstats
Rx only · Injection, Suspension · Intra-Articular

Methylprednisolone Acetate

Brands: Depo-Medrol · Medroloan Ii Suik · Medroloan Suik · Methylprednisolone Acetate

9 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US25 NDCs
9 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCD07AA01
RxCUI (US)6902
US makers9 labelers
Packages37
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 12 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$3.75$7.51$11.26$15.01May 2025Mar 2026Jul 2026
$9.353
Latest avg · Jul 22, 2026
-28%
Since May 21, 2025
9
Active US suppliers
49%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

39K79K118K158K2025 Q12025 Q22025 Q32025 Q42026 Q1
111K
Rx · 2026 Q1
188K
Units dispensed
-11%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it9 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Amneal Pharmaceuticals LLCunknown14SUPPLYING
Eugia US LLCunknown4SUPPLYING
A-S Medication Solutionsunknown4SUPPLYING
Asclemed USA, Inc.unknown3SUPPLYING
Sportpharm LLCunknown3SUPPLYING
Sagent Pharmaceuticalsunknown3SUPPLYING
Pharmacia & Upjohn Company LLCunknown2SUPPLYING
Endo USA, Inc.unknown2SUPPLYING
Caplin Steriles Limitedunknown2SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Apr 25, 2024
    RECALLRecall (Class II): MethylPREDNISolone Acetate Injectable Suspension, USP, 400 mg per 10 mL (40 mg per mL), 1 x 10 mL Multi-Dose Vial, Rx o…

    Presence of Particulate Matter: Potential for black particulates in the drug product. — Recalling firm: Sagent Pharmaceuticals — Nationwide in the USA

  • Feb 20, 2024
    RECALLRecall (Class II): Methylprednisolone acetate Injectable Suspension, USP, 400mg per 5mL (80mg/mL, 5mL Multiple-Dose Vial, Rx only, Mfd. in…

    Failed Dissolution Specifications — Recalling firm: Eugia US LLC — OH, TN, LA, MS

  • Jun 16, 2022
    SHORTAGEDrug shortage: Methylprednisolone Acetate Injection (Par Health, USA LLC)

    Methylprednisolone Acetate Injection — reported in shortage by Par Health, USA LLC. Therapeutic category: Rheumatology.

  • Dec 15, 2021
    SHORTAGEDrug shortage: Methylprednisolone Acetate Injection (Sagent Pharmaceuticals)

    Methylprednisolone Acetate Injection — reported in shortage by Sagent Pharmaceuticals. Therapeutic category: Rheumatology.

  • Dec 15, 2021
    SHORTAGEDrug shortage: Methylprednisolone Acetate Injection (Amneal Pharmaceuticals)

    Methylprednisolone Acetate Injection — reported in shortage by Amneal Pharmaceuticals. Therapeutic category: Rheumatology.

  • Dec 15, 2021
    SHORTAGEDrug shortage: Methylprednisolone Acetate Injection (Eugia US LLC)

    Methylprednisolone Acetate Injection — reported in shortage by Eugia US LLC. Therapeutic category: Rheumatology.